Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis
Fields of Study & Subjects
Advances in Cucurbitaceae Research
Natural Antidiabetic Agents Studies
Curcumin's Biomedical Applications
Publication details
- Journal / source
- Inflammopharmacology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 34
- Issue
- 7
- Pages
- 4463–4481
- Publication date
- 15 June 2026
- Language
- EN